Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q2FY26 scheduled to be held on November 06, 2025 at 05:00 P.M. (IST)
Date: October 29, 2025
To, Sr. General Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001
To, Sr. General Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E), Mumbai – 400 051
BSE Scrip Code: 544319
NSE Symbol: SENORES
Dear Sir/Madam,
Sub.: Intimation for Earnings Conference Call for Q2FY26
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that, post announcement of Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025, the Company will hold the earnings conference call for Q2FY26 on Thursday, November 06, 2025, at 05:00 P.M. (IST).
The details of the aforesaid earnings conference call are annexed herewith.
The audio recording and transcript of the aforesaid call will be subsequently published on the website of the Company and will be intimated accordingly.
You are requested to take the same on record.
Thanking you.
For Senores Pharmaceuticals Limited
Vinay Kumar Mishra Company Secretary and Compliance Officer ICSI Membership No.: F11464
Enclosures: As above
Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India
P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263
Q2FY26 Earnings Call Senores Pharmaceuticals Limited November 06, 2025 at 5:00 pm (IST)
Ambit Capital cordially invites you to the Q2FY26 Earnings Call of Senores Pharmaceuticals Limited
Company Representatives
Mr. Swapnil Shah – Managing Director
Mr. Sanjay Majmudar – Chairman
Mr. Deval Shah – Chief Financial Officer
The teleconference will be moderated by Pranav Chawla, Institutional Equities, Ambit Capital.
Conference Call Details Date: November 06, 2025 | Time: 5:00 pm (IST)
Please join the conference via Diamond Pass to avoid wait time. Please click here to register.
Primary Access Numbers
International Toll Free Numbers
We request you to dial in a few minutes prior to the scheduled time.
+91 22 6280 1148 +91 22 7115 8049
Singapore: 800 101 2045
Hong Kong: 800 964 448
USA: 1 866 746 2133
UK: 0 808 101 1573